EUVIMEDEUVIMED entdecken
Crossref

Dynamic Changes in NPAR and the CALLY Score for Predicting Pathological Complete Response in Breast Cancer: A Simple Combined Clinical Score

Bünyamin Güney, Özgür Han, Semih Sağır, Başak Çakır Güney, Didar Şenocak, Rıza Umar Gürsu

Clinical Breast Cancer · 2026-09 · 26 (9) · 114-120

DOI: 10.1016/j.clbc.2026.07.025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Breast Cancer, 2026-09. Verfasst von Bünyamin Güney und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Istanbul Training and Research Hospital, Istanbul, Türkiye. Electronic address: drbunyaminguney01@gmail.com. Hauptthemen laut MEDLINE: Breast Neoplasms, Neutrophils, Biomarkers, Tumor, Blood Platelets. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Pathological complete response (pCR) after neoadjuvant therapy is closely associated with improved survival in breast cancer, particularly in aggressive subtypes. In daily practice, treatment response is mainly evaluated using imaging modalities such as magnetic resonance imaging and ultrasonography; however, these methods may not always accurately reflect residual disease. Easily accessible and reliable laboratory-based markers are still lacking. Because systemic inflammation and nutritional status are closely linked to tumor biology, dynamic changes in composite indices may better reflect treatment response than baseline values alone. Therefore, evaluating treatment-related changes in such markers may provide a practical approach for early response assessment. METHODS: In this retrospective study, patients with histopathologically confirmed breast cancer who received neoadjuvant systemic therapy followed by surgery were included. The cohort consisted predominantly of stage II (43%) and stage III (57%) disease, with molecular subtypes representing a high-risk population. Changes in the neutrophil-to-platelet-albumin ratio (ΔNPAR) and creactive protein-albumin-lymphocyte (CALLY) score (ΔCALLY) between pretreatment and post-treatment periods were evaluated. Receiver operating characteristic curve analyses were performed, and optimal cutoff values were determined using the Youden index (-0.516 for ΔNPAR and 0.20 for ΔCALLY). For practical use, a simple combined score based on the direction of change was constructed (ΔNPAR 0). Logistic regression analysis was performed to identify independent predictors of pCR. RESULTS: The mean age of the patients was 52 ± 12 years. ΔNPAR showed moderate ability to predict pCR (area under the curve [AUC] 0.679; P < .001), with a sensitivity of 60.6% and specificity of 69.2%. ΔCALLY demonstrated similar performance (AUC 0.685; P < .001), with a sensitivity of 79.8% and specificity of 61.0%. The combined score improved predictive performance (AUC 0.755). Patients with the highest score had a pCR rate of 70.5%, with balanced sensitivity (78.7%) and specificity (78.8%). In multivariable analysis, the combined score was the only independent predictor of pCR (OR 23.5; P < .001). CONCLUSION: Changes in ΔNPAR and ΔCALLY, particularly when combined in a simple scoring system, were associated with pCR and may help identify patients with a higher likelihood of achieving pCR. These findings suggest that routinely available laboratory parameters may represent a cost-effective and clinically applicable tool for improving response assessment and supporting treatment decision-making in the neoadjuvant setting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsNeutrophilsBiomarkers, TumorBlood PlateletsAntineoplastic Combined Chemotherapy ProtocolsHumansFemalePathologic Complete ResponseRetrospective StudiesMiddle AgedNeoadjuvant TherapyPrognosisAdultROC CurveNeoplasm StagingAgedLymphocytes

Stichwörter der Autor:innen

Breast cancerInflammatory biomarkersNeoadjuvant therapyPrognostic markersTreatment response

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Medical Oncology, Istanbul Training and Research Hospital, Istanbul, Türkiye. Electronic address: drbunyaminguney01@gmail.com.
  • Department of Medical Oncology, Istanbul Training and Research Hospital, Istanbul, Türkiye.
  • Department of Internal Medicine, Memorial Hospitals, Istanbul, Türkiye.
  • Department of Medical Oncology, University of Health Sciences Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Türkiye.

Zitieren

APA

Güney, B., Han, Ö., Sağır, S., Çakır Güney, B., Şenocak, D., & Gürsu, R. U. (2026). Dynamic Changes in NPAR and the CALLY Score for Predicting Pathological Complete Response in Breast Cancer: A Simple Combined Clinical Score. Clinical Breast Cancer, 26(9), 114-120. https://doi.org/10.1016/j.clbc.2026.07.025

Vancouver

Güney B, Han Ö, Sağır S, Çakır Güney B, Şenocak D, Gürsu RU. Dynamic Changes in NPAR and the CALLY Score for Predicting Pathological Complete Response in Breast Cancer: A Simple Combined Clinical Score. Clinical Breast Cancer. 2026;26(9):114-120. doi:10.1016/j.clbc.2026.07.025

BibTeX
@article{Gney2026,
  author = {Güney, Bünyamin and Han, Özgür and Sağır, Semih and Çakır Güney, Başak and Şenocak, Didar and Gürsu, Rıza Umar},
  title = {Dynamic Changes in NPAR and the CALLY Score for Predicting Pathological Complete Response in Breast Cancer: A Simple Combined Clinical Score},
  journal = {Clinical Breast Cancer},
  year = {2026},
  volume = {26},
  number = {9},
  pages = {114--120},
  doi = {10.1016/j.clbc.2026.07.025}
}
Kostenlos starten →